Abstract
This cross-sectional study compares the number of insulin prescriptions filled before and during the COVID-19 pandemic.
Highlights
Using an interrupted time series design with segmented regression analysis, we examined whether the pandemic changed the number of new and existing insulin prescription fills in adults and children
This study found a considerable decrease in the average number of weekly insulin prescription fills during the COVID-19 pandemic
The lack of substantial decline in pediatric patients’ prescriptions can be explained by the fact that insulin use in pediatrics is more likely for type 1 diabetes
Summary
For the approximately 7 million US individuals with diabetes who rely on insulin, the number of insulin prescriptions rose steadily in the decade before the COVID-19 pandemic.. Reduced access to medical care and disruptions in supply related to the pandemic may have decreased access to insulin, with possible adverse consequences for diabetes control.. Emergency Medicaid expansions that increased capacity for telemedicine services during the pandemic may have been associated with improved access to treatment.. This study aimed to assess whether changes to insulin prescription claims occurred during the COVID-19 pandemic. Author affiliations and article information are listed at the end of this article. Trends in the Number of Insulin Prescriptions in the US From 2019 to 2020
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
